Credit Suisse Ag Tela Bio, Inc. Transaction History
Credit Suisse Ag
- $101 Billion
- Q1 2024
Shares
3 transactions
Others Institutions Holding TELA
# of Institutions
53Shares Held
26.9MCall Options Held
759KPut Options Held
100-
Essex Woodlands Management, Inc. The Woodlands, TX4.11MShares$10.7 Million2.87% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT3.68MShares$9.6 Million0.56% of portfolio
-
Silverarc Capital Management, LLC3.07MShares$8 Million2.23% of portfolio
-
Aigh Capital Management LLC Baltimore, MD2.66MShares$6.95 Million3.26% of portfolio
-
Stonepine Capital Management, LLC Bend, OR2.35MShares$6.14 Million5.74% of portfolio
About TELA Bio, Inc.
- Ticker TELA
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 19,157,600
- Market Cap $50M
- Description
- TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall recon...